Altitude Lab Startups Raise $154M in Capital
19 2월 2025 - 1:00AM
Today, Altitude Lab announced that its incubating startups have
collectively raised $154 million in early-stage funding since its
launch in 2020. Founded by Recursion, Altitude Lab supports diverse
life science entrepreneurs in Utah by providing fully equipped
laboratories, access to investors, business operations education,
and a collaborative founder community.In addition, Altitude Lab
awarded its inaugural Gibson Founder Fellowship to Carmen Kivisild,
Ph.D., CEO and founder of Elnora AI. The fellowship provides
early-career scientists with up to $150,000 in funding, scientific
support, and mentorship to accelerate the growth of their
startups.“Elnora AI is capturing real-world experimental data
directly from academic researchers—positive, negative, and
everything in between. This enables our AI-powered lab protocol
optimizer, helping researchers get their experiments working faster
while building the most comprehensive dataset for drug discovery,”
said Kivisild. “The Gibson Fellowship gave us critical funding and
an anchor community as we relocated from Estonia to Utah. It’s a
once-in-a-lifetime opportunity to be mentored by Chris Gibson,
Recursion’s CEO and founder, while rapidly scaling Elnora at
Altitude Lab.”Applications for the 2025 Gibson Founder Fellowship
are now open.“In 2025, we anticipate a wave of Series A funding
rounds from our alumni and broader founder community,” said
Chandana Haque, executive director of Altitude Lab. “Our founders
achieved major value inflection points in 2024, and we are thrilled
to see them continue scaling.”
Key Milestones from Altitude Lab’s Portfolio:
- 19 startups in Altitude Lab’s current cohort and 12 alumni
- 70% of startups are led by at least one underrepresented
founder
- 90% of all participating startups have raised capital
- Peel Therapeutics completed a Phase 1 trial for its PEEL-224
TOP1 inhibitor and closed the first tranche of its Series A
- Rebel Medicine received IND approval for Alevatrix and closed
the first tranche of its Series A
- Sethera established Dr. Robert Langer, MIT faculty and
co-founder of Moderna, as chair of their Scientific Advisory
Board
- Teiko launched a 25-marker spectral flow cytometry assay on
fixed whole blood, combining high-throughput immune measurement of
~150 populations with extended stability for global clinical
trials.
Applications to join Altitude Lab’s newest cohort are now open.
Learn more and apply for residency and the Founder Fellowship at
altitudelab.org.
About Altitude LabAltitude Lab is building a new, representative
generation of founders to seed the next cycle of health care
innovation in Utah’s BioHive. Currently located in Gateway’s
BioHive Hub in Salt Lake City, Altitude Lab is an accelerator
program focused on early stage life science and health care
companies. The initiative is part of a larger city plan and
collaborative vision from Recursion to foster socially-responsible
entrepreneurship, job creation, and economic productivity. The
Recursion Foundation, under which Altitude Lab operates, is a
501(c)(3) nonprofit organization.Learn more at altitudelab.org or
connect on X.About RecursionRecursion (NASDAQ: RXRX) is a clinical
stage TechBio company leading the space by decoding biology to
radically improve lives. Enabling its mission is the Recursion OS,
a platform built across diverse technologies that continuously
generate one of the world’s largest proprietary biological and
chemical datasets. Recursion leverages sophisticated
machine-learning algorithms to distill from its dataset a
collection of trillions of searchable relationships across biology
and chemistry unconstrained by human bias. By commanding massive
experimental scale — up to millions of wet lab experiments weekly —
and massive computational scale — owning and operating one of the
most powerful supercomputers in the world, Recursion is uniting
technology, biology and chemistry to advance the future of
medicine.Recursion is headquartered in Salt Lake City, where it is
a founding member of BioHive, the Utah life sciences industry
collective. Recursion also has offices in Toronto, Montréal, New
York, London, Oxford area, and the San Francisco Bay area. Learn
more at recursion.com, or connect on X (formerly Twitter) and
LinkedIn.
Media Contact
Media@Recursion.com
Investor Contact
Investor@Recursion.com
Recursion Pharmaceuticals (NASDAQ:RXRX)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025
Recursion Pharmaceuticals (NASDAQ:RXRX)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025